Bruker (BRKR) FCF Payout Ratio Growth (3y) (2018 - 2026)
Powered by 
Analysis
Bruker (BRKR) FCF Payout Ratio Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 240.72 Bn | 236.78 Bn | 8.34 Bn | -0.94% |
| 2 | Danaher | 148.85 Bn | 144.52 Bn | 3.61 Bn | 17.90% |
| 3 | Agilent Technologies | 44.12 Bn | 42.36 Bn | 1.04 Bn | 6.13% |
| 4 | Illumina | 36.18 Bn | 35.01 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.01 Bn | 14.98 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.30 Bn | 11.03 Bn | 211.39 Mn | -6.13% |
| 7 | Twist Bioscience | 10.47 Bn | 10.30 Bn | 62.45 Mn | - |
| 8 | Bio-Rad Laboratories | 10.05 Bn | 8.43 Bn | 345.80 Mn | - |
| 9 | Repligen | 9.98 Bn | 8.97 Bn | 110.04 Mn | - |
| 10 | Bruker | 9.35 Bn | 9.17 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.21% |
| Mar 31, 2026 | 10.95% |
| Dec 31, 2025 | 10.72% |
| Sep 30, 2025 | -30.53% |
| Jun 30, 2025 | 24.86% |
| Mar 31, 2025 | 15.68% |
| Dec 31, 2024 | -3.08% |
| Sep 30, 2024 | 17.75% |
| Jun 30, 2024 | 66.31% |
| Mar 31, 2024 | 503.04% |
| Dec 31, 2023 | 6.21% |
| Sep 30, 2023 | 65.06% |
| Jun 30, 2023 | 65.85% |
| Mar 31, 2023 | -55.87% |
| Dec 31, 2022 | -1.99% |
| Sep 30, 2022 | 54.13% |
| Jun 30, 2022 | 47.90% |
| Mar 31, 2022 | -58.23% |
| Dec 31, 2021 | -1.08% |
| Sep 30, 2021 | 143.05% |